These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24368265)

  • 1. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study.
    Alcarraz-Vizán G; Sánchez-Tena S; Moyer MP; Cascante M
    Biochim Biophys Acta; 2014 Jun; 1840(6):1634-9. PubMed ID: 24368265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicatechin gallate impairs colon cancer cell metabolic productivity.
    Sánchez-Tena S; Alcarraz-Vizán G; Marín S; Torres JL; Cascante M
    J Agric Food Chem; 2013 May; 61(18):4310-7. PubMed ID: 23594085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells.
    Liu Y; He G; Wang Y; Guan X; Pang X; Zhang B
    Toxicol Lett; 2013 Jul; 221(1):23-30. PubMed ID: 23770000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors.
    Amoêdo ND; Rodrigues MF; Pezzuto P; Galina A; da Costa RM; de Almeida FC; El-Bacha T; Rumjanek FD
    PLoS One; 2011; 6(7):e22264. PubMed ID: 21789245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells.
    Fanciulli M; Bruno T; Castiglione S; Del Carlo C; Paggi MG; Floridi A
    Oncol Res; 1993; 5(9):357-62. PubMed ID: 8038456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29.
    Vizán P; Alcarraz-Vizán G; Díaz-Moralli S; Solovjeva ON; Frederiks WM; Cascante M
    Int J Cancer; 2009 Jun; 124(12):2789-96. PubMed ID: 19253370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
    Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
    Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
    Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors.
    Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V
    Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of intracellular phosphorylated carbohydrates in HT29 human colon adenocarcinoma cell line using liquid chromatography-electrospray ionization tandem mass spectrometry.
    Vizán P; Alcarraz-Vizán G; Díaz-Moralli S; Rodríguez-Prados JC; Zanuy M; Centelles JJ; Jáuregui O; Cascante M
    Anal Chem; 2007 Jul; 79(13):5000-5. PubMed ID: 17523595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation.
    Boren J; Lee WN; Bassilian S; Centelles JJ; Lim S; Ahmed S; Boros LG; Cascante M
    J Biol Chem; 2003 Aug; 278(31):28395-402. PubMed ID: 12750369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells.
    Rodrigues MF; Carvalho É; Pezzuto P; Rumjanek FD; Amoêdo ND
    J Cell Biochem; 2015 May; 116(5):797-808. PubMed ID: 25510910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of differentiation of colon cancer cells by combined inhibition of kinases and histone deacetylase.
    Lea MA; Ibeh C; Shah N; Moyer MP
    Anticancer Res; 2007; 27(2):741-8. PubMed ID: 17465197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma cells show an energy producing anabolic metabolic phenotype compared with primary myocytes.
    Fan TW; Kucia M; Jankowski K; Higashi RM; Ratajczak J; Ratajczak MZ; Lane AN
    Mol Cancer; 2008 Oct; 7():79. PubMed ID: 18939998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex.
    Blouin JM; Penot G; Collinet M; Nacfer M; Forest C; Laurent-Puig P; Coumoul X; Barouki R; Benelli C; Bortoli S
    Int J Cancer; 2011 Jun; 128(11):2591-601. PubMed ID: 20715114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
    Mariadason JM; Corner GA; Augenlicht LH
    Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
    Hsu YF; Sheu JR; Lin CH; Yang DS; Hsiao G; Ou G; Chiu PT; Huang YH; Kuo WH; Hsu MJ
    Biochim Biophys Acta; 2012 Feb; 1820(2):104-15. PubMed ID: 22155142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.